Optimization of antibacterial therapy to minimize costs, medication errors, and adverse outcomes

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

As noted in the widely publicized Institute of Medicine report, medical errors are a major cause of mortality, morbidity, and excess health care costs (1). A substantial portion of these medical errors are medication errors that lead to preventable adverse drug events (ADEs). In the United States, the estimated cost of a preventable ADE ranges from $2, 600 to $6, 800 (based on year 2000 values) in hospitalized patients and from $700 to $2, 200 in outpatients requiring emergency department evaluation or hospital admission. When extrapolated to a nationwide basis, the combined annual cost is in the range of $2 billion to $3 billion (2). Antibacterial agents represent the class of drugs most cited as the subject of ADEs (3, 4). Furthermore, the adverse effects attributable to antibacterial agents are not limited to minor reactions. This class has been found to be a major cause of fatal ADEs (5).

Original languageEnglish (US)
Title of host publicationAntibiotic Optimization
Subtitle of host publicationConcepts and Strategies in Clinical Practice
PublisherCRC Press
Pages89-114
Number of pages26
ISBN (Electronic)9780203996928
ISBN (Print)9780824754310
StatePublished - Jan 1 2004

Fingerprint

Medication Errors
Drug-Related Side Effects and Adverse Reactions
Costs and Cost Analysis
Medical Errors
Anti-Bacterial Agents
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Therapeutics
Health Care Costs
Hospital Emergency Service
Outpatients
Morbidity
Mortality
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Nix, D. E., & Erstad, B. L. (2004). Optimization of antibacterial therapy to minimize costs, medication errors, and adverse outcomes. In Antibiotic Optimization: Concepts and Strategies in Clinical Practice (pp. 89-114). CRC Press.

Optimization of antibacterial therapy to minimize costs, medication errors, and adverse outcomes. / Nix, David E.; Erstad, Brian L.

Antibiotic Optimization: Concepts and Strategies in Clinical Practice. CRC Press, 2004. p. 89-114.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nix, DE & Erstad, BL 2004, Optimization of antibacterial therapy to minimize costs, medication errors, and adverse outcomes. in Antibiotic Optimization: Concepts and Strategies in Clinical Practice. CRC Press, pp. 89-114.
Nix DE, Erstad BL. Optimization of antibacterial therapy to minimize costs, medication errors, and adverse outcomes. In Antibiotic Optimization: Concepts and Strategies in Clinical Practice. CRC Press. 2004. p. 89-114
Nix, David E. ; Erstad, Brian L. / Optimization of antibacterial therapy to minimize costs, medication errors, and adverse outcomes. Antibiotic Optimization: Concepts and Strategies in Clinical Practice. CRC Press, 2004. pp. 89-114
@inbook{11470da3e64044619b02c74903359f4f,
title = "Optimization of antibacterial therapy to minimize costs, medication errors, and adverse outcomes",
abstract = "As noted in the widely publicized Institute of Medicine report, medical errors are a major cause of mortality, morbidity, and excess health care costs (1). A substantial portion of these medical errors are medication errors that lead to preventable adverse drug events (ADEs). In the United States, the estimated cost of a preventable ADE ranges from $2, 600 to $6, 800 (based on year 2000 values) in hospitalized patients and from $700 to $2, 200 in outpatients requiring emergency department evaluation or hospital admission. When extrapolated to a nationwide basis, the combined annual cost is in the range of $2 billion to $3 billion (2). Antibacterial agents represent the class of drugs most cited as the subject of ADEs (3, 4). Furthermore, the adverse effects attributable to antibacterial agents are not limited to minor reactions. This class has been found to be a major cause of fatal ADEs (5).",
author = "Nix, {David E.} and Erstad, {Brian L}",
year = "2004",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780824754310",
pages = "89--114",
booktitle = "Antibiotic Optimization",
publisher = "CRC Press",

}

TY - CHAP

T1 - Optimization of antibacterial therapy to minimize costs, medication errors, and adverse outcomes

AU - Nix, David E.

AU - Erstad, Brian L

PY - 2004/1/1

Y1 - 2004/1/1

N2 - As noted in the widely publicized Institute of Medicine report, medical errors are a major cause of mortality, morbidity, and excess health care costs (1). A substantial portion of these medical errors are medication errors that lead to preventable adverse drug events (ADEs). In the United States, the estimated cost of a preventable ADE ranges from $2, 600 to $6, 800 (based on year 2000 values) in hospitalized patients and from $700 to $2, 200 in outpatients requiring emergency department evaluation or hospital admission. When extrapolated to a nationwide basis, the combined annual cost is in the range of $2 billion to $3 billion (2). Antibacterial agents represent the class of drugs most cited as the subject of ADEs (3, 4). Furthermore, the adverse effects attributable to antibacterial agents are not limited to minor reactions. This class has been found to be a major cause of fatal ADEs (5).

AB - As noted in the widely publicized Institute of Medicine report, medical errors are a major cause of mortality, morbidity, and excess health care costs (1). A substantial portion of these medical errors are medication errors that lead to preventable adverse drug events (ADEs). In the United States, the estimated cost of a preventable ADE ranges from $2, 600 to $6, 800 (based on year 2000 values) in hospitalized patients and from $700 to $2, 200 in outpatients requiring emergency department evaluation or hospital admission. When extrapolated to a nationwide basis, the combined annual cost is in the range of $2 billion to $3 billion (2). Antibacterial agents represent the class of drugs most cited as the subject of ADEs (3, 4). Furthermore, the adverse effects attributable to antibacterial agents are not limited to minor reactions. This class has been found to be a major cause of fatal ADEs (5).

UR - http://www.scopus.com/inward/record.url?scp=85057472859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057472859&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85057472859

SN - 9780824754310

SP - 89

EP - 114

BT - Antibiotic Optimization

PB - CRC Press

ER -